Literature DB >> 23960822

Paclitaxel loaded carrier based biodegradable polymeric implants: Preparation and in vitro characterization.

Jagadeesh G Hiremath1, Nirav S Khamar, Subhash G Palavalli, Chetan G Rudani, Rajeshkumar Aitha, Prasanthkumar Mura.   

Abstract

The objective of this study was to develop paclitaxel (PTX) loaded poly(ε-caprolactone) (PCL) based tiny implants. β-Cyclodextrin (β-CD) and polyethylene glycol (PEG 6000) were used to enhance solubility and release of the drug in the phosphate buffer saline pH 7.4. Implants were evaluated in terms of color, shape, thickness, surface area, weight, drug content. Developed implants were characterized for their surface morphology (SEM analysis), drug physical state by thermal analysis (DSC studies), crystalline nature (XRD studies) and drug excipients compatibility (FT-IR spectroscopy). Macroscopically all the tiny implants were white in color and cylindrical in shape with smooth surfaces. PTX was entrapped within implants in the polymeric amorphous form. In vitro drug release studies showed prolonged and controlled release of PTX with zero order and Korsmeyer-Peppas model being exhibited. Excipients and method of preparation did not affect chemical stability of PTX.

Entities:  

Keywords:  Implants; Paclitaxel (PTX); Poly(ε-caprolactone); β-Cyclodextrin

Year:  2012        PMID: 23960822      PMCID: PMC3745043          DOI: 10.1016/j.jsps.2011.12.002

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  12 in total

Review 1.  Modeling and comparison of dissolution profiles.

Authors:  P Costa; J M Sousa Lobo
Journal:  Eur J Pharm Sci       Date:  2001-05       Impact factor: 4.384

Review 2.  New treatment strategies for malignant gliomas.

Authors:  N G Avgeropoulos; T T Batchelor
Journal:  Oncologist       Date:  1999

3.  Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel--effect of additives.

Authors:  Ariella Shikanov; Aviva Ezra; Abraham J Domb
Journal:  J Control Release       Date:  2005-06-20       Impact factor: 9.776

Review 4.  Pharmacology and toxicology of Cremophor EL diluent.

Authors:  R T Dorr
Journal:  Ann Pharmacother       Date:  1994-05       Impact factor: 3.154

5.  Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxel-eluting stent application.

Authors:  Xi Liu; Lei Lei; Jing-Wen Hou; Mu-Fei Tang; Sheng-Rong Guo; Zhong-Min Wang; Ke-Min Chen
Journal:  J Mater Sci Mater Med       Date:  2011-01-08       Impact factor: 3.896

Review 6.  Paclitaxel and its formulations.

Authors:  Anil K Singla; Alka Garg; Deepika Aggarwal
Journal:  Int J Pharm       Date:  2002-03-20       Impact factor: 5.875

7.  A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment.

Authors:  Yangqing Zhang; Lina Tang; Leilei Sun; Junbo Bao; Cunxian Song; Laiqiang Huang; Kexin Liu; Yan Tian; Ge Tian; Zhen Li; Hongfan Sun; Lin Mei
Journal:  Acta Biomater       Date:  2009-12-05       Impact factor: 8.947

Review 8.  Poly-epsilon-caprolactone microspheres and nanospheres: an overview.

Authors:  V R Sinha; K Bansal; R Kaushik; R Kumria; A Trehan
Journal:  Int J Pharm       Date:  2004-06-18       Impact factor: 5.875

Review 9.  Taxol: the first of the taxanes, an important new class of antitumor agents.

Authors:  E K Rowinsky; N Onetto; R M Canetta; S G Arbuck
Journal:  Semin Oncol       Date:  1992-12       Impact factor: 4.929

Review 10.  Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.

Authors:  C M Spencer; D Faulds
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

View more
  6 in total

1.  Paclitaxel-loaded PLGA microspheres with a novel morphology to facilitate drug delivery and antitumor efficiency.

Authors:  Zongrui Zhang; Xinyu Wang; Binbin Li; Yuanjing Hou; Zhengwei Cai; Jing Yang; Yi Li
Journal:  RSC Adv       Date:  2018-01-16       Impact factor: 4.036

2.  Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy.

Authors:  Hima Bindu Ruttala; Young Tag Ko
Journal:  Pharm Res       Date:  2014-09-12       Impact factor: 4.200

3.  Thermosensitive and mucoadhesive sol-gel composites of paclitaxel/dimethyl-β-cyclodextrin for buccal delivery.

Authors:  Soon Gil Choi; Sang-Eun Lee; Bong-Seok Kang; Choon Lian Ng; Enkhzaya Davaa; Jeong-Sook Park
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

4.  Comparative studies of salinomycin-loaded nanoparticles prepared by nanoprecipitation and single emulsion method.

Authors:  Qin Wang; Puyuan Wu; Wei Ren; Kai Xin; Yang Yang; Chen Xie; Chenchen Yang; Qin Liu; Lixia Yu; Xiqun Jiang; Baorui Liu; Rutain Li; Lifeng Wang
Journal:  Nanoscale Res Lett       Date:  2014-07-15       Impact factor: 4.703

5.  Exceedingly Higher co-loading of Curcumin and Paclitaxel onto Polymer-functionalized Reduced Graphene Oxide for Highly Potent Synergistic Anticancer Treatment.

Authors:  Kasturi Muthoosamy; Ibrahim Babangida Abubakar; Renu Geetha Bai; Hwei-San Loh; Sivakumar Manickam
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

6.  Synthesis and Evaluation of 177Lu-DOTA-DN(PTX)-BN for Selective and Concomitant Radio and Drug-Therapeutic Effect on Breast Cancer Cells.

Authors:  Brenda Gibbens-Bandala; Enrique Morales-Avila; Guillermina Ferro-Flores; Clara Santos-Cuevas; Myrna Luna-Gutiérrez; Gerardo Ramírez-Nava; Blanca Ocampo-García
Journal:  Polymers (Basel)       Date:  2019-09-27       Impact factor: 4.329

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.